CT
AZN icon

Clearstead Trust’s AstraZeneca AZN Stock Holding History

Clearstead Trust’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$396K Hold
2,089
– – 0.05% 131
2026
Q1 		$412K Sell
2,089
-5
-0.2% -$964 0.07% 126
2025
Q4 		$385K Hold
2,094
– – 0.06% 135
2025
Q3 		$321K Sell
2,094
-58
-3% -$8.78K 0.05% 142
2025
Q2 		$301K Sell
2,152
-1
-0% -$140 0.06% 139
2025
Q1 		$317K Sell
2,153
-53
-2% -$7.67K 0.07% 124
2024
Q4 		$289K Buy
2,206
+1,950
+762% +$273K 0.06% 123
2024
Q3 		$39.8K Buy
256
+2
+0.8% +$323 0.01% 258
2024
Q2 		$39.6K Hold
254
– – 0.01% 253
2024
Q1 		$34.4K Buy
254
+3
+1% +$397 0.01% 267
2023
Q4 		$33.7K Hold
251
– – 0.01% 258
2023
Q3 		$33.9K Buy
251
+2
+0.8% +$273 0.01% 246
2023
Q2 		$35.6K Hold
249
– – 0.01% 229
2023
Q1 		$34.5K Buy
249
+3
+1% +$404 0.01% 233
2022
Q4 		$33K Hold
246
– – 0.01% 250
2022
Q3 		$27K Buy
+246
New +$31.2K 0.01% 236
2018
Q2 		– Sell
-1,190
Closed -$83K – 205
2018
Q1 		$83K Hold
1,190
– – 0.07% 109
2017
Q4 		$83K Hold
1,190
– – 0.06% 134
2017
Q3 		$81K Hold
1,190
– – 0.06% 147
2017
Q2 		$58K Hold
1,190
– – 0.05% 154
2017
Q1 		$74K Hold
1,190
– – 0.06% 111
2016
Q4 		$65K Buy
+1,190
New +$67.6K 0.06% 116

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Clearstead Trust's AZN Position: Q2 2026 in Review

Clearstead Trust held its AstraZeneca (AZN) position steady in Q2 2026 at 2,089 shares worth $396K. The position accounts for 0.05% of the portfolio, ranked #131.

Clearstead Trust first reported a position in AZN in Q4 2016 and has held it in 22 quarters since. The position peaked at $412K in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Clearstead Trust held 2,089 shares of AstraZeneca worth $396K as of Q2 2026.
  • Clearstead Trust left its AstraZeneca share count unchanged in Q2 2026.
  • AstraZeneca made up 0.05% of Clearstead Trust's portfolio in Q2 2026, its #131 holding.
  • Clearstead Trust first reported a position in AstraZeneca in Q4 2016 and has held it in 22 quarters since.
  • Clearstead Trust's AstraZeneca position peaked at $412K in Q1 2026.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Clearstead Trust's 13F filing for Q2 2026, filed 6 Aug 2026.